Clinical Trial Update: Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating whether tumor bed boost radiotherapy can be omitted for patients achieving pathologic complete response after breast-conserving surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING